Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Non-Current Deferred Tax Liability (2009 - 2026)

Evotec SE's (EVO) quarterly Non-Current Deferred Tax Liability came in at $11.9 million in Q2 2026, down 23.06% year-over-year from $15.5 million in Q2 2025, and down 19.52% quarter-over-quarter from $14.8 million in Q1 2026.

Analysis

Evotec SE (EVO) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Non-Current Deferred Tax Liability across 9 years of filings, most recently posting $11.9 million for Q2 2026.

  • In Q2 2026, Non-Current Deferred Tax Liability fell 23.06% year-over-year to $11.9 million; the TTM figure through Jun 2026 stood at $11.9 million (down 23.06% YoY), while the FY2025 annual figure was $16.6 million, up 5.96% from the prior year.
  • Non-Current Deferred Tax Liability came in at $11.9 million for Q2 2026 at Evotec SE, down from $14.8 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $20.8 million in Q2 2023 to a low of $11.9 million in Q2 2026.
  • Average Non-Current Deferred Tax Liability over 5 years is $16.7 million, with a median of $15.9 million recorded in 2025.
  • Year-over-year, Non-Current Deferred Tax Liability fell 23.53% in 2022 and grew 10.58% in 2025.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $18.9 million in 2022, then climbed by 3.26% to $19.5 million in 2023, then declined by 20.51% to $15.5 million in 2024, then climbed by 10.58% to $17.2 million in 2025, then sank by 30.41% to $11.9 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $11.9 million in Q2 2026, $14.8 million in Q1 2026, and $17.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn
6 Evotec SE 642.83 Mn 216.96 Mn -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn
10 VivoSim Labs 1.45 Mn 1.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.94 Mn
Mar 31, 2026 14.83 Mn
Dec 31, 2025 17.15 Mn
Sep 30, 2025 15.95 Mn
Jun 30, 2025 15.51 Mn
Mar 31, 2025 14.24 Mn
Dec 31, 2024 15.51 Mn
Sep 30, 2024 15.43 Mn
Dec 31, 2023 19.51 Mn
Jun 30, 2023 20.83 Mn
Dec 31, 2022 18.90 Mn
Sep 30, 2022 17.32 Mn
Mar 31, 2022 19.70 Mn
Dec 31, 2021 20.23 Mn
Sep 30, 2021 22.65 Mn
Dec 31, 2020 24.32 Mn
Sep 30, 2010 8.50 Mn
Jun 30, 2010 3.19 Mn
Mar 31, 2010 2,539.56
Dec 31, 2009 2.92 Mn